论文部分内容阅读
Objective Our purpose was to perform a meta-analysis of randomized controlled trials evaluating safety and efficacy in 2-year of everolimus-eluting stents (EES) compared with paclitaxei-eluting stents (PES), in patients undergoing percutaneous coronary intervention (PCI).